Table of Content

1 Hormonal Contraception Market Overview
1.1 Product Overview and Scope of Hormonal Contraception
1.2 Hormonal Contraception Segment by Hormone
1.2.1 Global Hormonal Contraception Sales Growth Rate Comparison by Hormone (2021-2027)
1.2.2 Androgens
1.2.3 Estrogens
1.2.4 Progestrogens
1.2.5 Antiandrogens
1.2.6 Gonadotropins
1.3 Hormonal Contraception Segment by Application
1.3.1 Hormonal Contraception Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Gynaecology Centers
1.3.5 Others
1.4 Global Hormonal Contraception Market Size Estimates and Forecasts
1.4.1 Global Hormonal Contraception Revenue 2016-2027
1.4.2 Global Hormonal Contraception Sales 2016-2027
1.4.3 Hormonal Contraception Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hormonal Contraception Market Competition by Manufacturers
2.1 Global Hormonal Contraception Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hormonal Contraception Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hormonal Contraception Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hormonal Contraception Manufacturing Sites, Area Served, Product Type
2.5 Hormonal Contraception Market Competitive Situation and Trends
2.5.1 Hormonal Contraception Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hormonal Contraception Players Market Share by Revenue
2.5.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hormonal Contraception Retrospective Market Scenario by Region
3.1 Global Hormonal Contraception Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Hormonal Contraception Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Hormonal Contraception Market Facts & Figures by Country
3.3.1 North America Hormonal Contraception Sales by Country
3.3.2 North America Hormonal Contraception Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hormonal Contraception Market Facts & Figures by Country
3.4.1 Europe Hormonal Contraception Sales by Country
3.4.2 Europe Hormonal Contraception Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hormonal Contraception Market Facts & Figures by Region
3.5.1 Asia Pacific Hormonal Contraception Sales by Region
3.5.2 Asia Pacific Hormonal Contraception Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hormonal Contraception Market Facts & Figures by Country
3.6.1 Latin America Hormonal Contraception Sales by Country
3.6.2 Latin America Hormonal Contraception Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hormonal Contraception Market Facts & Figures by Country
3.7.1 Middle East and Africa Hormonal Contraception Sales by Country
3.7.2 Middle East and Africa Hormonal Contraception Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hormonal Contraception Historic Market Analysis by Type
4.1 Global Hormonal Contraception Sales Market Share by Type (2016-2021)
4.2 Global Hormonal Contraception Revenue Market Share by Type (2016-2021)
4.3 Global Hormonal Contraception Price by Type (2016-2021)

5 Global Hormonal Contraception Historic Market Analysis by Application
5.1 Global Hormonal Contraception Sales Market Share by Application (2016-2021)
5.2 Global Hormonal Contraception Revenue Market Share by Application (2016-2021)
5.3 Global Hormonal Contraception Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer AG Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporation Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck & Co., Inc. Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 Pfizer, Inc.
6.3.1 Pfizer, Inc. Corporation Information
6.3.2 Pfizer, Inc. Description and Business Overview
6.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer, Inc. Product Portfolio
6.3.5 Pfizer, Inc. Recent Developments/Updates
6.4 Agile Therapeutics, Inc.
6.4.1 Agile Therapeutics, Inc. Corporation Information
6.4.2 Agile Therapeutics, Inc. Description and Business Overview
6.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Agile Therapeutics, Inc. Product Portfolio
6.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Industries Ltd. Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amgen Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Cipla Ltd.
6.6.1 Cipla Ltd. Corporation Information
6.6.2 Cipla Ltd. Description and Business Overview
6.6.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cipla Ltd. Product Portfolio
6.7.5 Cipla Ltd. Recent Developments/Updates
6.8 Glenmark Pharmaceuticals Inc.
6.8.1 Glenmark Pharmaceuticals Inc. Corporation Information
6.8.2 Glenmark Pharmaceuticals Inc. Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Glenmark Pharmaceuticals Inc. Product Portfolio
6.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
6.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
6.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
6.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
6.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Product Portfolio
6.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Novartis AG Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Mylan N.V.
6.11.1 Mylan N.V. Corporation Information
6.11.2 Mylan N.V. Hormonal Contraception Description and Business Overview
6.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Mylan N.V. Product Portfolio
6.11.5 Mylan N.V. Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Corporation Information
6.12.2 Johnson & Johnson Hormonal Contraception Description and Business Overview
6.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Johnson & Johnson Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Ansell LTD
6.13.1 Ansell LTD Corporation Information
6.13.2 Ansell LTD Hormonal Contraception Description and Business Overview
6.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ansell LTD Product Portfolio
6.13.5 Ansell LTD Recent Developments/Updates
6.14 Mayer Laboratories, Inc.
6.14.1 Mayer Laboratories, Inc. Corporation Information
6.14.2 Mayer Laboratories, Inc. Hormonal Contraception Description and Business Overview
6.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Mayer Laboratories, Inc. Product Portfolio
6.14.5 Mayer Laboratories, Inc. Recent Developments/Updates

7 Hormonal Contraception Manufacturing Cost Analysis
7.1 Hormonal Contraception Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hormonal Contraception
7.4 Hormonal Contraception Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hormonal Contraception Distributors List
8.3 Hormonal Contraception Customers

9 Hormonal Contraception Market Dynamics
9.1 Hormonal Contraception Industry Trends
9.2 Hormonal Contraception Growth Drivers
9.3 Hormonal Contraception Market Challenges
9.4 Hormonal Contraception Market Restraints

10 Global Market Forecast
10.1 Hormonal Contraception Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hormonal Contraception by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hormonal Contraception by Type (2022-2027)
10.2 Hormonal Contraception Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hormonal Contraception by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Hormonal Contraception by Application (2022-2027)
10.3 Hormonal Contraception Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hormonal Contraception by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hormonal Contraception by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Hormonal Contraception Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hormonal Contraception Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Hormonal Contraception Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hormonal Contraception Covered in This Study
Table 5. Global Hormonal Contraception Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Hormonal Contraception Sales Share by Manufacturers (2016-2021)
Table 7. Global Hormonal Contraception Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hormonal Contraception Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hormonal Contraception Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hormonal Contraception Manufacturing Sites and Area Served
Table 11. Manufacturers Hormonal Contraception Product Type
Table 12. Global Hormonal Contraception Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hormonal Contraception by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hormonal Contraception as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hormonal Contraception Sales by Region (2016-2021) & (K Units)
Table 16. Global Hormonal Contraception Sales Market Share by Region (2016-2021)
Table 17. Global Hormonal Contraception Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hormonal Contraception Sales by Country (2016-2021) & (K Units)
Table 19. North America Hormonal Contraception Sales Market Share by Country (2016-2021)
Table 20. North America Hormonal Contraception Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hormonal Contraception Revenue Market Share by Country (2016-2021)
Table 22. Europe Hormonal Contraception Sales by Country (2016-2021) & (K Units)
Table 23. Europe Hormonal Contraception Sales Market Share by Country (2016-2021)
Table 24. Europe Hormonal Contraception Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hormonal Contraception Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hormonal Contraception Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Hormonal Contraception Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hormonal Contraception Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hormonal Contraception Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hormonal Contraception Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Hormonal Contraception Sales Market Share by Country (2016-2021)
Table 32. Latin America Hormonal Contraception Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hormonal Contraception Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hormonal Contraception Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Hormonal Contraception Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hormonal Contraception Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hormonal Contraception Revenue Market Share by Country (2016-2021)
Table 38. Global Hormonal Contraception Sales (K Units) by Type (2016-2021)
Table 39. Global Hormonal Contraception Sales Market Share by Type (2016-2021)
Table 40. Global Hormonal Contraception Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hormonal Contraception Revenue Share by Type (2016-2021)
Table 42. Global Hormonal Contraception Price (US$/Unit) by Type (2016-2021)
Table 43. Global Hormonal Contraception Sales (K Units) by Application (2016-2021)
Table 44. Global Hormonal Contraception Sales Market Share by Application (2016-2021)
Table 45. Global Hormonal Contraception Revenue (Million US$) by Application (2016-2021)
Table 46. Global Hormonal Contraception Revenue Share by Application (2016-2021)
Table 47. Global Hormonal Contraception Price (US$/Unit) by Application (2016-2021)
Table 48. Bayer AG Corporation Information
Table 49. Bayer AG Description and Business Overview
Table 50. Bayer AG Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Bayer AG Hormonal Contraception Product
Table 52. Bayer AG Recent Developments/Updates
Table 53. Merck & Co., Inc. Corporation Information
Table 54. Merck & Co., Inc. Description and Business Overview
Table 55. Merck & Co., Inc. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Merck & Co., Inc. Hormonal Contraception Product
Table 57. Merck & Co., Inc. Recent Developments/Updates
Table 58. Pfizer, Inc. Corporation Information
Table 59. Pfizer, Inc. Description and Business Overview
Table 60. Pfizer, Inc. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer, Inc. Hormonal Contraception Product
Table 62. Pfizer, Inc. Recent Developments/Updates
Table 63. Agile Therapeutics, Inc. Corporation Information
Table 64. Agile Therapeutics, Inc. Description and Business Overview
Table 65. Agile Therapeutics, Inc. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Agile Therapeutics, Inc. Hormonal Contraception Product
Table 67. Agile Therapeutics, Inc. Recent Developments/Updates
Table 68. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 69. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 70. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product
Table 72. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 73. Amgen Corporation Information
Table 74. Amgen Description and Business Overview
Table 75. Amgen Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Amgen Hormonal Contraception Product
Table 77. Amgen Recent Developments/Updates
Table 78. Cipla Ltd. Corporation Information
Table 79. Cipla Ltd. Description and Business Overview
Table 80. Cipla Ltd. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Cipla Ltd. Hormonal Contraception Product
Table 82. Cipla Ltd. Recent Developments/Updates
Table 83. Glenmark Pharmaceuticals Inc. Corporation Information
Table 84. Glenmark Pharmaceuticals Inc. Description and Business Overview
Table 85. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product
Table 87. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
Table 88. Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
Table 89. Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
Table 90. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product
Table 92. Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
Table 93. Novartis AG Corporation Information
Table 94. Novartis AG Description and Business Overview
Table 95. Novartis AG Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Novartis AG Hormonal Contraception Product
Table 97. Novartis AG Recent Developments/Updates
Table 98. Mylan N.V. Corporation Information
Table 99. Mylan N.V. Description and Business Overview
Table 100. Mylan N.V. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Mylan N.V. Hormonal Contraception Product
Table 102. Mylan N.V. Recent Developments/Updates
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Johnson & Johnson Hormonal Contraception Product
Table 107. Johnson & Johnson Recent Developments/Updates
Table 108. Ansell LTD Corporation Information
Table 109. Ansell LTD Description and Business Overview
Table 110. Ansell LTD Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Ansell LTD Hormonal Contraception Product
Table 112. Ansell LTD Recent Developments/Updates
Table 113. Mayer Laboratories, Inc. Corporation Information
Table 114. Mayer Laboratories, Inc. Description and Business Overview
Table 115. Mayer Laboratories, Inc. Hormonal Contraception Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Mayer Laboratories, Inc. Hormonal Contraception Product
Table 117. Mayer Laboratories, Inc. Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Hormonal Contraception Distributors List
Table 121. Hormonal Contraception Customers List
Table 122. Hormonal Contraception Market Trends
Table 123. Hormonal Contraception Growth Drivers
Table 124. Hormonal Contraception Market Restraints
Table 125. Global Hormonal Contraception Sales Forecast by Type (2022-2027) & (K Units)
Table 126. Global Hormonal Contraception Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Hormonal Contraception Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Hormonal Contraception Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Hormonal Contraception Sales Forecast by Application (2022-2027) & (K Units)
Table 130. Global Hormonal Contraception Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Hormonal Contraception Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Hormonal Contraception Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Hormonal Contraception Sales Forecast by Region (2022-2027) & (K Units)
Table 134. Global Hormonal Contraception Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Hormonal Contraception Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Hormonal Contraception Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hormonal Contraception
Figure 2. Global Hormonal Contraception Market Share by Type in 2020 & 2027
Figure 3. Androgens Product Picture
Figure 4. Estrogens Product Picture
Figure 5. Progestrogens Product Picture
Figure 6. Antiandrogens Product Picture
Figure 7. Gonadotropins Product Picture
Figure 8. Global Hormonal Contraception Market Share by Application in 2020 & 2027
Figure 9. Hospital
Figure 10. Clinics
Figure 11. Gynaecology Centers
Figure 12. Others
Figure 13. Global Hormonal Contraception Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Hormonal Contraception Market Size 2016-2027 (US$ Million)
Figure 15. Global Hormonal Contraception Sales 2016-2027 (K Units)
Figure 16. Global Hormonal Contraception Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Hormonal Contraception Sales Share by Manufacturers in 2020
Figure 18. Global Hormonal Contraception Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Hormonal Contraception Players: Market Share by Revenue in 2020
Figure 20. Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Hormonal Contraception Sales Market Share by Region (2016-2021)
Figure 22. Global Hormonal Contraception Sales Market Share by Region in 2020
Figure 23. Global Hormonal Contraception Revenue Market Share by Region (2016-2021)
Figure 24. Global Hormonal Contraception Revenue Market Share by Region in 2020
Figure 25. U.S. Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Hormonal Contraception Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Hormonal Contraception by Type (2016-2021)
Figure 50. Sales Market Share of Hormonal Contraception by Application (2016-2021)
Figure 51. Sales Market Share of Hormonal Contraception by Application in 2020
Figure 52. Revenue Share of Hormonal Contraception by Application (2016-2021)
Figure 53. Revenue Share of Hormonal Contraception by Application in 2020
Figure 54. Manufacturing Cost Structure of Hormonal Contraception
Figure 55. Manufacturing Process Analysis of Hormonal Contraception
Figure 56. Hormonal Contraception Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed